| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |